New Metastatic Melanoma Therapies Create Hope for Patients, Key Role for Oncology Nurses
The incidence of melanoma, the deadliest of all skin cancers, is quickly rising, and the disease is responsible for more than 8000 deaths each year.
Opportunity Knocks: New ACoS Standard Requires Navigation Process in Place by 2015
Facilities seeking Commission on Cancer accreditation now need to have a patient navigation process in place by 2015.
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
